Research
Raymond James Initiates Coverage on Tonix Pharmaceuticals With Strong Buy Rating, $26 PT
Tonix Pharmaceuticals Holding (TNXP) has an average rating of Buy and mean price target of $44.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$TNXP
